Assessing the Preparedness and Knowledge of Pharmacists in the Current Monkeypox Outbreak

Sponsor

Beni-Suef University (Other)

Overall Status

Recruiting

CT.gov ID

NCT05543577

Collaborator

(none)

380

Enrollment

Location

2.6

Anticipated Duration (Months)

148.3

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

General objective: to measure the preparedness of pharmacists and medical interns about monkeypox

Specific objectives: to evaluate the level of knowledge among pharmacists and medical interns about monkeypox treatment and nature of disease

Condition or Disease	Intervention/Treatment	Phase
Monkey Pox	Other: Questionnaire

Detailed Description

Globally, the ongoing outbreak was declared as a public health emergency. After the first laboratory-confirmed case of monkeypox was reported in Singapore on May 2019, countries all over the world started to strengthen disease surveillance systems. One challenge in preventing monkeypox is a lack of knowledge, particularly among healthcare workers.

Study significance: to examine in detail the preparedness and the perception of pharmacists and medical interns about monkeypox and to evaluate the level of knowledge about monkeypox management and nature of disease.

Study Design

Study Type:

Observational

Anticipated Enrollment :

380 participants

Observational Model:

Other

Time Perspective:

Cross-Sectional

Official Title:

Comparative Study of the Preparedness and Knowledge of Pharmacists Versus Intern Physician in the Current Monkeypox Outbreak

Actual Study Start Date :

Sep 14, 2022

Anticipated Primary Completion Date :

Nov 15, 2022

Anticipated Study Completion Date :

Dec 1, 2022

Arms and Interventions

Arm	Intervention/Treatment
Pharmacists community, hospital and clinical pharmacists	Other: Questionnaire Questionnaire
Medical interns Medical interns of both sexes	Other: Questionnaire Questionnaire

Arm

Intervention/Treatment

Pharmacists

community, hospital and clinical pharmacists

Other: Questionnaire

Questionnaire

Medical interns

Medical interns of both sexes

Other: Questionnaire

Questionnaire

Outcome Measures

Primary Outcome Measures

to evaluate the level of knowledge among pharmacists and medical interns about monkeypox treatment and nature of disease [2 months]
to evaluate the level of knowledge among pharmacists and medical interns about monkeypox treatment and nature of disease

Eligibility Criteria

Criteria

Ages Eligible for Study:

N/A and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

community, hospital and clinical pharmacists, Medical interns of both sexes

Exclusion Criteria:

any other healthcare professional

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	BeniSuefU	Minya		Egypt

Sponsors and Collaborators

Beni-Suef University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.

Responsible Party:

Asmaa Abdelfattah Elsayed, Assistant lecturer, Beni-Suef University

ClinicalTrials.gov Identifier:

NCT05543577

Other Study ID Numbers:

BeniSuefU2022

First Posted:

Sep 16, 2022

Last Update Posted:

Sep 16, 2022

Last Verified:

Sep 1, 2022

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

Monkeypox

Study Results

No Results Posted as of Sep 16, 2022